Double-blind, placebo-controlled study of oxacillin combined with rifampin in the treatment of staphylococcal infections.
A total of 101 patients with proven Staphylococcus aureus infection were included in a double-blind, placebo-controlled study; this study compared oxacillin (12 g/day, intravenously) or vancomycin (2 g/day, intravenously) plus rifampin (1,200 mg/day, orally) with oxacillin or vancomycin plus placebo...
Sparad:
| I publikationen: | Antimicrob Agents Chemother |
|---|---|
| Huvudupphov: | , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Utgiven: |
American Society for Microbiology (ASM)
1985
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC180285/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3907494/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.28.4.467 |
| Taggar: |
Inga taggar, Lägg till första taggen!
|